Pancreatic Cancer Research

ResearcherLoma Linda UniversityNo recent work listed

Chung-Tsen Hsueh

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1409-0030; OpenAlex author ID A5050866892. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 3

  1. A phase II trial of gemcitabine and erlotinib followed by ChemoProton therapy plus capecitabine and oxaliplatin for locally advanced pancreatic cancer. Co-author DOI 10.21037/jgo-22-327↗
  2. Nanovectors for anti-cancer drug delivery in the treatment of advanced pancreatic adenocarcinoma. Last author DOI 10.3748/wjg.v22.i31.7080↗
  3. Pancreatic cancer: current standards, research updates and future directions. Co-author DOI 10.3978/j.issn.2078-6891.2011.037↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Samrat M. Sanghvi · 1 shared paper, 2022 · strength 0.15
  2. Alex Coffman · 1 shared paper, 2022 · strength 0.15
  3. Gary Yang · 1 shared paper, 2022 · strength 0.15
  4. Chung-Tzu Hsueh · 1 shared paper, 2016 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.